Atara Biotherapeutics (ATRA) EBITDA (2013 - 2026)
Atara Biotherapeutics (ATRA) EBITDA from Sep 30, 2013 to Mar 31, 2026. The TTM Atara Biotherapeutics (ATRA) EBITDA is -$5.96M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EBITDA
Quarterly EBITDA
Atara Biotherapeutics (ATRA) EBITDA CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -24.84% |
| 3 Years TTM | -71.67% |
| 5 Years TTM | -54.45% |
| 10 Years TTM | -21.39% |
| All Time TTM | -8.95% |
Annual EBITDA change of Atara Biotherapeutics (ATRA)
| Year | EBITDA | Change |
|---|---|---|
| 2026 | -$3.34M | -108.79% |
| 2025 | $38M | -148.45% |
| 2024 | -$78M | -71.09% |
| 2023 | -$271M | -1.34% |
| 2022 | -$275M | -16.99% |
| 2021 | -$331M | +10.11% |
| 2020 | -$301M | +4.20% |
| 2019 | -$289M | +23.67% |
| 2018 | -$233M | +93.55% |
| 2017 | -$121M | +49.12% |
| 2016 | -$81M | +38.46% |
| 2015 | -$58M | +107.46% |
| 2014 | -$28M | +226.95% |
| 2013 | -$8.61M | +110.51% |
| 2012 | -$4.09M | N/A |
Comparison Atara Biotherapeutics (ATRA) five years EBITDA CAGR with competitors
Atara Biotherapeutics (ATRA) five years EBITDA CAGR is -54.45%.